Breast cancer study comparing younger and older patients
Treatments studied
Part of Cancer, Skin clinical trials.
This trial looks at differences between younger and older breast cancer patients to better understand the disease. If you had breast cancer between the ages of 18 and 75 and were treated in a Chinese hospital from 2000 to 2024, you might be able to help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were first diagnosed and treated for breast cancer between January 2000 and December 2024.
- You were between 18 and 75 years old at the time of diagnosis.
- You were treated at one of the several hospitals in China taking part in this study.
- You do not have another type of cancer.
- You do not have a chronic infectious disease like HIV or severe organ problems (such as heart, liver, or kidney failure).
- You are not currently in any other condition that would make the study unsafe, as judged by the study doctor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares outcomes in older breast cancer patients who had different types of surgery, like wide local excision (removing just the tumor) versus other procedures. It aims to see if less extensive surgery works as well, which may help guide future treatment choices for elderly patients.
This study looks at breast cancer in women diagnosed at or before age 45 or at or after age 55. Researchers want to understand how the reproductive cycle might affect how aggressive the cancer is.
This study looks at how age-related changes in your blood might affect how well your breast cancer treatment works. It includes people with hormone receptor-positive, HER2-negative breast cancer that has not spread to distant organs.
This study looks at how “early aging” changes show up during treatment in young adults with cancer. It may help doctors better understand health effects during curative therapy and improve care for people your age.
This study looks at the genetic changes in breast cancer patients, especially those with a family history or early onset. It may help doctors understand which genes are common in Chinese breast cancer patients and guide future treatment options.
This study looks at the potential harms and benefits of hormone (endocrine) therapy in people age 70 and older with early-stage, hormone-receptor–positive breast cancer. It may help doctors choose which hormone treatment approach is safest and most helpful for older patients.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.